Head and Neck Cancer.

作者信息

Chow Laura Q M

机构信息

From the Division of Medical Oncology, Department of Medicine, University of Washington, Thoracic, Head, and Neck Malignancies, Seattle Cancer Care Alliance, and Fred Hutchinson Cancer Research Center - all in Seattle.

出版信息

N Engl J Med. 2020 Jan 2;382(1):60-72. doi: 10.1056/NEJMra1715715.

DOI:10.1056/NEJMra1715715

PMID:31893516

Abstract

摘要

相似文献

[1]

Head and Neck Cancer.

N Engl J Med. 2020-1-2

[2]

Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.

Eur J Cancer. 2016-11

[3]

Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.

Cancer. 2016-2-15

[4]

Management of human papillomavirus-related head and neck cancer.

Curr Probl Dermatol. 2014

[5]

Expanding role of the medical oncologist in the management of head and neck cancer.

CA Cancer J Clin. 2008

[6]

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).

Int J Cancer. 2015-7-30

[7]

Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.

Jpn J Clin Oncol. 2012-8-23

[8]

Head and Neck Cancer - New Insights into a Heterogeneous Disease.

Oncol Res Treat. 2017

[9]

Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.

Cancer. 2017-5-15

[10]

The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Int J Cancer. 2017-8-1

引用本文的文献

[1]

SPINK1 facilitates tumor progression via the EGFR/JAK/STAT3 axis in oral squamous cell carcinoma: insights from single-cell RNA sequencing.

Front Oncol. 2025-8-19

[2]

Feature level quantitative ultrasound and CT information fusion to predict the outcome of head & neck cancer radiotherapy treatment: Enhanced principal component analysis.

Med Phys. 2025-9

[3]

Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors.

Cancer Diagn Progn. 2025-9-1

[4]

Recent advances in tumor targeted polymeric nanoparticles for HNC treatment: Enhancing therapeutic efficacy via engineered and biocompatible drug delivery systems.

J Oral Biol Craniofac Res. 2025

[5]

Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application.

Front Immunol. 2025-8-11

[6]

Immunotherapy in Head and Neck Cancer.

Cancer Treat Res. 2025

[7]

Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study.

Front Immunol. 2025-8-6

[8]

Cancer care coordination determinants of depression in head and neck cancer survivors.

Support Care Cancer. 2025-8-20

[9]

Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives.

Discov Nano. 2025-8-18

[10]

Effect of a Probiotic Combination on Clinical and Microbiological Oral Parameters in Head and Neck Cancer Patients: A Randomised Clinical Trial.

Cancers (Basel). 2025-7-25

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Head and Neck Cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献